Recklinghausen (von), disease

[MIM 162 200162 210613 675]

(Neurofibromatosis type I)

Prevalence: 1/2,500 live births.

Hereditary and peripheral phakomatosis with multisystemic involvement with variable clinical expression and severity. Autosomal dominant transmission with variable penetrance of a mutation of the NF1 gene on 17q11.2 but there is a high rate of de novo mutations (40-50 %). This gene codes for neurofibromin that inactivates cell proliferation and tumor development.

Clinical picture:

-        cutaneous manifestations: cafe au lait spots (minimum 6, measuring more than 5 mm before puberty and 15 mm after puberty), lentigines (freckles resembling small spots) in the axillary and inguinal level (children and teens) (80%), cutaneous neurofibromas (often itchy nodules, small subcutaneous tumors that follow a nerve pathway, sometimes large infiltrating masses called plexiform neuromas

-        iridial Lisch nodules (coloured iridial hamartoma detectable on slit lamp examination, in 85-90 % of the children over 10 years)

-        extracutaneous neurologic manifestations: neurofibromas on the roots of spinal or autonomous nerves, glioma of the chiasma, spinal cord tumors (Astrocytoma, ependymoma), macrocephaly, damage to cerebral arteries (Moyamoya);

-        bone abnormalities: congenital pseudarthrosis of the tibia, scoliosis, dysplasia of the sphenoid;

-        other conditions: arterial hypertension caused by stenosis of the renal artery or by the secretion of catecholamines in plexiform neurofibromas.

-        tumors: Wilms, rhabdomyosarcoma, risk of pheochromocytoma.

-        sometimes: short stature, precocious puberty


Anesthetic implications:

difficult intubation in case of facial or oro-pharyngeal neurofibromas. Prudence when performing a neuraxial block. Risk of arterial hypertension. In case of kyphoscoliosis, check the stability of the cervical spine


References :  


Updated: October 2018